Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Nature Reviews. Cardiology|June 27, 2025
Tailored therapeutics for cardiomyopathiesAthanasios Bakalakos, Emanuele Monda, Perry Mark ElliottThe Canadian Journal of Cardiology|March 6, 2024
The Diagnostic and Therapeutic Implications of Phenocopies and Mimics of Hypertrophic CardiomyopathyAthanasios Bakalakos, Emanuele Monda, Perry Mark ElliottEuropean Journal of Medical Genetics|November 18, 2023
Cardiovascular involvement in later-onset malonyl-CoA decarboxylase deficiency: Case studies and literature reviewEmanuele Monda, Athanasios Bakalakos, Petros Syrris, et al.Heart (British Cardiac Society)|April 30, 2024
Incidence and risk factors for development of left ventricular hypertrophy in Fabry diseaseEmanuele Monda, Athanasios Bakalakos, Robin Lachmann, et al.JACC. Heart Failure|April 4, 2024
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis: A Systematic Review and Meta-AnalysisEmanuele Monda, Athanasios Bakalakos, Douglas Cannie, et al.Circulation. Genomic and Precision Medicine|December 4, 2023
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening StudiesEmanuele Monda, Gaetano Diana, Francesca Graziani, et al.Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 29, 2018
Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of viewAthanasios Bakalakos, Konstantinos Ritsatos, Aris AnastasakisJournal of Thoracic Disease|March 31, 2018
The J-waves of hypothermiaPanagiotis Mililis, George Bazoukis, Athanasios Bakalakos, et al.JACC. Heart Failure|June 10, 2026
Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic CardiomyopathyAthanasios Bakalakos, Alexandros Protonotarios, Menelaos Pavlou, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 14, 2012
Risk stratification in hypertrophic cardiomyopathy: time for renewal?Giuseppe Pacileo, Gemma Salerno, Rita Gravino, et al.Pageof 4